Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning
The world is facing the COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Likewise, other viruses of the Coronaviridae family were responsible for causing epidemics earlier. To tackle these viruses, there is a lack of approved antiviral drugs. Therefore, we ha...
Main Authors: | Akanksha Rajput, Anamika Thakur, Adhip Mukhopadhyay, Sakshi Kamboj, Amber Rastogi, Sakshi Gautam, Harvinder Jassal, Manoj Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S200103702100218X |
Similar Items
-
Artificial intelligence approach fighting COVID-19 with repurposing drugs
by: Yi-Yu Ke, et al.
Published: (2020-08-01) -
Repurposing old drugs as antiviral agents for coronaviruses
by: Cheng-Wei Yang, et al.
Published: (2020-08-01) -
Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
by: Jennifer Santos, et al.
Published: (2020-06-01) -
AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate
by: Marcin Delijewski, et al.
Published: (2021-03-01) -
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
by: Yogesh Kumar, et al.
Published: (2020-09-01)